As we all know, after anti-programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) got satisfying results in most cancers, CTLA-4 has also made breakthroughs in the immunotherapy of various tumors. Here, PDCD1 is linked to cancer.